Results 181 to 190 of about 69,036 (281)

Machine learning models for the prediction of levodopa response to tremor in Parkinson's disease. [PDF]

Front Aging Neurosci
Li F, Lin S, Yan R, Cui Y, Ren K, Chen Z, Ma L, Feng T.   +7 more
europepmc   +1 more source

Long‐Term Exposure to Air Pollution and Incidence of Parkinson's Disease: A Danish Nationwide Administrative Cohort Study

Movement Disorders, EarlyView.
Abstract Background Long‐term exposure to air pollution has been linked to Parkinson's disease (PD) incidence, yet evidence is mixed, partly because of challenges with PD diagnosis and definition. We examined this association in a nationwide administrative cohort.
Thomas Cole‐Hunter, Sonja Antic, Youn‐Hee Lim, Jiawei Zhang, Laust Hvas Mortensen, Kees de Hoogh, Steffen Loft, George Maria Napolitano, Stéphane Tuffier, Marie Laura Bergmann, Bert Brunekreef, Gerard Hoek, Beate Ritz, Zorana Jovanovic Andersen, Rina So   +14 more
wiley   +1 more source

Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial.

JAMA Neurol
Fernandez HH, Isaacson SH, Hauser RA, Agarwal P, Ondo W, Park A, Kremens D, Leoni M, Duvvuri S, Combs C, Koenig E, Chang I, Pastino G, Tringali S, Golonski N, Sanchez R, Harmer L, Boiser J, Zadikoff C, Mari Z.   +19 more
europepmc   +1 more source

Real-world data of opicapone in patients with Parkinson's disease experiencing motor fluctuations: the OPTIMO study. [PDF]

Front Neurol
Luquin MR, Lopez-Ariztegui N, Castrillo JCM, Manzanares LL, Bataller IS, Fernández AK, Pastor BV, Vila BS, Sauco MÁ, Mora JP, González JMA, Ruiz-Espiga PJG, de Fàbregues O, Del Val JL, Arillo VC, Moreno C, Ameijeiras JB, Jiménez IP, Ayuela IT.   +18 more
europepmc   +1 more source

Excess risk of fracture in incident Parkinson's disease Medicare beneficiaries. [PDF]

Inj Epidemiol
Camacho-Soto A, Faust IM, Krzyzanowski B, Killion JA, Beyene KM, Ellerbeck EF, Sosnoff JJ, Racette BA.   +7 more
europepmc   +1 more source

Missense Variants in the A Isoform of FGF13 as a Novel Cause of Paroxysmal Dyskinesia

Movement Disorders, EarlyView.
Abstract Background Pathogenic variants within the unique N‐terminal inactivation particle of FGF13 isoform A (FGF13A) have so far been associated only with an X‐linked dominant epileptic encephalopathy (DEE). Objective The aim was to expand the clinical and molecular spectrum of FGF13A‐related disorder.
Cyril Mignot, Matthildi Athina Papathanasiou Terzi, Claudia Ravelli, Elisabeth Bosch, Xueqin Lin, Adeline Trauffler, Roseline Caumes, Andrew E. Fry, Clementine Fort, Gaelle Gauthe, Regina Trollmann, Thomas Wirth, Mathieu Anheim, Aurélie Méneret, Emmanuel Roze, Jean‐Madeleine de Sainte Agathe, Hailan He, Eleni Panagiotakaki, Gaëtan Lesca, André Reis, Diane Doummar, Thomas Smol, Georgia Vasileiou   +22 more
wiley   +1 more source

Differentiating effects of levodopa and subthalamic nucleus deep brain stimulation on motor features in Parkinson disease. [PDF]

Clin Park Relat Disord
Lee TA, Ramesh D, Ushe M, Norris SA, Tabbal SD, Perlmutter JS, Younce JR.   +6 more
europepmc   +1 more source

When the Scale Drops: Pathways to Weight Loss in Parkinson's Disease and Future Directions

Movement Disorders, EarlyView.
Abstract Although Parkinson's disease (PD) is classically defined by its motor features, non‐motor symptoms exert a substantial and often under‐recognized influence on disease trajectory. Among these, weight loss has long been observed in PD and other neurodegenerative disorders, yet the mechanisms remain incompletely understood.
Ellie D. Gabriel, Robert S. Eisinger, Joyce M. Lee, Sarah Hamimi, Hope Kim, Susanna D. Howard, Casey H. Halpern   +6 more
wiley   +1 more source

Effects of deep brain stimulation on non motor fluctuations in Parkinson's disease (assessed with the NMF severity scale). [PDF]

Clin Park Relat Disord
Matta C, Comet C, Gaillard C, Faggianelli F, Grimaldi S, Witjas T, Ansquer S, Hubsch C, Anheim M, Moreau C, Hainque E, Drapier S, Jarraya B, Laurencin C, Guehl D, Hopes L, Brefel-Courbon C, Tir M, Marques A, Rouaud T, Maltete D, Giordana C, Baumstarck K, Rascol O, Corvol JC, Ory-Magne F, Rolland AS, Devos D, Azulay JP, Eusebio A, PREDISTIM Study Group.   +30 more
europepmc   +1 more source

The mitogenome mutation repertoire affects progression of Parkinson's Disease. [PDF]

Genet Mol Biol
Matos GB, Santos CSD, Macêdo LCC, Diniz JPDS, Sousa TP, Cavalcante GC, Silva CS, Cruz RLDS, Moura DD, Ribeiro-Dos-Santos A, Santos-Lobato BL, Araújo GS.   +11 more
europepmc   +1 more source